Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KDM6B | O15054 | 1/20 | 0.32 |
| ▸ | KDM5C | P41229 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11095630 | 0.90 | PHF8 (0.46) | TSHRALDH1A1LMNAKDM4EKDM6B | |
| SCHEMBL29577467 | 0.89 | TSHR (0.48) | TSHRCA12CA14USP2ALDH1A1 | |
| SCHEMBL18126395 | 0.89 | TSHR (0.42) | TSHRCA12CA14USP2ALDH1A1 | |
| SCHEMBL28930135 | 0.88 | PHF8 (0.45) | TSHRALDH1A1LMNAKDM4EKDM6B | |
| SCHEMBL2454800 | 0.87 | ALDH1A1 (0.52) | TSHRCA12CA14ALDH1A1LMNA | |
| SCHEMBL18126348 | 0.87 | DGKA (0.41) | TSHRUSP2ALDH1A1LMNAKDM4E | |
| SCHEMBL18126466 | 0.87 | DGKA (0.41) | TSHRUSP2ALDH1A1LMNAKDM4E | |
| SCHEMBL1177201 | 0.84 | KDM4E (0.55) | TSHRLMNAKDM4E | |
| SCHEMBL27639020 | 0.83 | CES1 (0.44) | TSHRCA12CA14ALDH1A1LMNA | |
| SCHEMBL28430222 | 0.82 | MGAM (0.39) | TSHRCA12CA14USP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107849493-B | Defect reducing rinse solution containing ammonium salts of sulfoesters | 巴斯夫欧洲公司 | 2020-10-09 | — | — | CN | claimed |
| CN-109996778-B | Taste modifying aldehydes | 高砂香料工业株式会社 | 2022-12-13 | — | — | CN | disclosed |
| CN-113347994-B | Treatment and prevention of cancer using HER3 antigen binding molecules | 蜂鸟生物科技私人有限公司 | 2022-09-23 | — | — | CN | disclosed |
| CN-114507285-A | VISTA antigen binding molecules | 蜂鸟生物科技私人有限公司 | 2022-05-17 | — | — | CN | disclosed |
| CN-112513080-B | VISTA antigen binding molecules | 蜂鸟生物科技控股有限公司 | 2022-03-08 | — | — | CN | disclosed |
| CN-112513095-B | HER3 antigen binding molecules | 蜂鸟生物科技控股有限公司 | 2022-03-08 | — | — | CN | disclosed |
| CN-109803948-B | Warming sensation compound | 高砂香料工业株式会社 | 2022-03-01 | — | — | CN | disclosed |
| CN-113347994-A | Treatment and prevention of cancer using HER3 antigen binding molecules | 蜂鸟生物科技控股私人有限公司 | 2021-09-03 | — | — | CN | disclosed |
| CN-112912393-A | Engineered FC | 蜂鸟生物科技控股私人有限公司 | 2021-06-04 | — | — | CN | disclosed |
| CN-112513080-A | VISTA antigen binding molecules | 蜂鸟生物科技控股私人有限公司 | 2021-03-16 | — | — | CN | disclosed |
| CN-112513095-A | HER3 antigen binding molecules | 蜂鸟生物科技控股私人有限公司 | 2021-03-16 | — | — | CN | disclosed |
| CN-107849493-B | Defect reducing rinse solution containing ammonium salts of sulfoesters | 巴斯夫欧洲公司 | 2020-10-09 | — | — | CN | disclosed |
| CN-111417653-A | CD47 antigen binding molecules | 蜂鸟生物科技控股私人有限公司 | 2020-07-14 | — | — | CN | disclosed |
| US-9130244-B2 | Nonaqueous electrolyte solution and electrochemical element using same | UBE INDUSTRIES, LTD. (JP) | 2015-09-08 | — | — | US | disclosed |
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | UBE INDUSTRIES, LTD. (JP) | 2012-07-05 | — | — | US | disclosed |
| EP-1187805-A1 | PROCESS FOR PREPARING R-(-)-CARNITINE FROM S-(-)-CHLOROSUCCINIC ACID OR FROM A DERIVATIVE THEREOF | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2002-03-20 | — | — | EP | disclosed |
| WO-2000069808-A1 | PROCESS FOR PREPARING R-(-)-CARNITINE FROM S-(-)-CHLOROSUCCINIC ACID OR FROM A DERIVATIVE THEREOF | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2000-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120171581-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTROCHEMICAL ELEMENT USING SAME | SLC8A1, OR10J3, SLC8B1 | TSHR 3669/4885CA12 270/4885CA14 247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.